Real time quote data is not available at this time. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

We recently published a list of Top 10 Penny Stocks That Will Skyrocket. In this article, we are going to take a look at ...

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares closed lower on Monday potentially following the company's announcement of Dan Kirby as Chief Commercial Officer. Shares of Iovance ...

IOVA) saw its share price during the last trading day of the year rise by 3.21 percent, ending the day at $7.40 apiece. According to analysts, investors resorted to bargain-hunting after the ...

Stock analysts at Zacks Research issued their FY2027 earnings per share estimates for shares of Iovance Biotherapeutics in a ...

Short interest is currently not available. Nasdaq provides information of company’s short interest and the average days it takes to cover them. Short interest and days to cover can be used to ...

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report)’s share price dropped 5.8% on Tuesday after Truist Financial ... traded hands during mid-day trading, a decline of 12% from ...

IOVA) reported fourth quarter 2024 financial results that fell short of analyst expectations on the revenue front, sending shares down 5.3% in after-hours trading. The commercial-stage ...

Iovance Biotherapeutics, Inc. IOVA incurred a fourth-quarter 2024 loss of 26 cents per share, narrower than the Zacks Consensus Estimate of a loss of 27 cents. In the year-ago quarter, the company ...

IOVA) has plunged ~18% after warning that geopolitical instability, wars, and inflation could harm its business. "We are currently operating in a period of economic uncertainty and capital markets ...

Iovance Biotherapeutics (IOVA) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.45 per share a year ago.